Next Article in Journal
Studies in the Use of Magnetic Microspheres for Immunoaffinity Extraction of Paralytic Shellfish Poisoning Toxins from Shellfish
Next Article in Special Issue
Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool
Previous Article in Journal / Special Issue
Strategy for Treating Motor Neuron Diseases Using a Fusion Protein of Botulinum Toxin Binding Domain and Streptavidin for Viral Vector Access: Work in Progress
Review

Botulinum Neurotoxin for Pain Management: Insights from Animal Models

CNR, Institute of Neuroscience-Roma, via del Fosso di Fiorano 64, I-00143 Roma, Italy
*
Author to whom correspondence should be addressed.
Toxins 2010, 2(12), 2890-2913; https://doi.org/10.3390/toxins2122890
Received: 18 November 2010 / Revised: 17 December 2010 / Accepted: 20 December 2010 / Published: 21 December 2010
(This article belongs to the Special Issue Toxins as Therapeutics)
The action of botulinum neurotoxins (BoNTs) at the neuromuscular junction has been extensively investigated and knowledge gained in this field laid the foundation for the use of BoNTs in human pathologies characterized by excessive muscle contractions. Although much more is known about the action of BoNTs on the peripheral system, growing evidence has demonstrated several effects also at the central level. Pain conditions, with special regard to neuropathic and intractable pain, are some of the pathological states that have been recently treated with BoNTs with beneficial effects. The knowledge of the action and potentiality of BoNTs utilization against pain, with emphasis for its possible use in modulation and alleviation of chronic pain, still represents an outstanding challenge for experimental research. This review highlights recent findings on the effects of BoNTs in animal pain models. View Full-Text
Keywords: botulinum toxin; SNARE; pain; animal model; analgesia; inflammatory pain; chronic pain; peripheral sensitization; central sensitization; retrograde axonal transport botulinum toxin; SNARE; pain; animal model; analgesia; inflammatory pain; chronic pain; peripheral sensitization; central sensitization; retrograde axonal transport
Show Figures

Graphical abstract

MDPI and ACS Style

Pavone, F.; Luvisetto, S. Botulinum Neurotoxin for Pain Management: Insights from Animal Models. Toxins 2010, 2, 2890-2913. https://doi.org/10.3390/toxins2122890

AMA Style

Pavone F, Luvisetto S. Botulinum Neurotoxin for Pain Management: Insights from Animal Models. Toxins. 2010; 2(12):2890-2913. https://doi.org/10.3390/toxins2122890

Chicago/Turabian Style

Pavone, Flaminia, and Siro Luvisetto. 2010. "Botulinum Neurotoxin for Pain Management: Insights from Animal Models" Toxins 2, no. 12: 2890-2913. https://doi.org/10.3390/toxins2122890

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop